Treatment of KPC-2 Enterobacter cloacae empyema with cefepime and levofloxacin

Anthony P. Cardile; Heather Briggs; S. Rodrigo Burguete; Monica Herrera; Brian L. Wickes; James H. Jorgensen

doi:10.1016/j.diagmicrobio.2013.10.012

Treatment of KPC-2 Enterobacter cloacae empyema with cefepime and levofloxacin

Anthony P. Cardile, Heather Briggs, S. Rodrigo Burguete, Monica Herrera, Brian L. Wickes, James H. Jorgensen

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Carbapenem-resistant Enterobacteriaceae infections are becoming more common, are associated with high mortality rates, and are difficult to treat due to multiple mechanisms of resistance. We describe the successful treatment of Klebsiella pneumoniae carbapenemase-expressing Enterobacter cloacae empyema in a lung transplant recipient with cefepime and levofloxacin.

Original language	English (US)
Pages (from-to)	199-200
Number of pages	2
Journal	Diagnostic Microbiology and Infectious Disease
Volume	78
Issue number	2
DOIs	https://doi.org/10.1016/j.diagmicrobio.2013.10.012
State	Published - Feb 2014

Keywords

Carbapenemase
Empyema
Enterobacter cloacae
KPC

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1016/j.diagmicrobio.2013.10.012

Cite this

@article{fef61d24988b40d7935e6ad52bf294a3,

title = "Treatment of KPC-2 Enterobacter cloacae empyema with cefepime and levofloxacin",

abstract = "Carbapenem-resistant Enterobacteriaceae infections are becoming more common, are associated with high mortality rates, and are difficult to treat due to multiple mechanisms of resistance. We describe the successful treatment of Klebsiella pneumoniae carbapenemase-expressing Enterobacter cloacae empyema in a lung transplant recipient with cefepime and levofloxacin.",

keywords = "Carbapenemase, Empyema, Enterobacter cloacae, KPC",

author = "Cardile, {Anthony P.} and Heather Briggs and Burguete, {S. Rodrigo} and Monica Herrera and Wickes, {Brian L.} and Jorgensen, {James H.}",

year = "2014",

month = feb,

doi = "10.1016/j.diagmicrobio.2013.10.012",

language = "English (US)",

volume = "78",

pages = "199--200",

journal = "Diagnostic Microbiology and Infectious Disease",

issn = "0732-8893",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Treatment of KPC-2 Enterobacter cloacae empyema with cefepime and levofloxacin

AU - Cardile, Anthony P.

AU - Briggs, Heather

AU - Burguete, S. Rodrigo

AU - Herrera, Monica

AU - Wickes, Brian L.

AU - Jorgensen, James H.

PY - 2014/2

Y1 - 2014/2

N2 - Carbapenem-resistant Enterobacteriaceae infections are becoming more common, are associated with high mortality rates, and are difficult to treat due to multiple mechanisms of resistance. We describe the successful treatment of Klebsiella pneumoniae carbapenemase-expressing Enterobacter cloacae empyema in a lung transplant recipient with cefepime and levofloxacin.

AB - Carbapenem-resistant Enterobacteriaceae infections are becoming more common, are associated with high mortality rates, and are difficult to treat due to multiple mechanisms of resistance. We describe the successful treatment of Klebsiella pneumoniae carbapenemase-expressing Enterobacter cloacae empyema in a lung transplant recipient with cefepime and levofloxacin.

KW - Carbapenemase

KW - Empyema

KW - Enterobacter cloacae

KW - KPC

UR - http://www.scopus.com/inward/record.url?scp=84892479419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892479419&partnerID=8YFLogxK

U2 - 10.1016/j.diagmicrobio.2013.10.012

DO - 10.1016/j.diagmicrobio.2013.10.012

M3 - Article

C2 - 24268534

AN - SCOPUS:84892479419

SN - 0732-8893

VL - 78

SP - 199

EP - 200

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

IS - 2

ER -

Treatment of KPC-2 Enterobacter cloacae empyema with cefepime and levofloxacin

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this